A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

NCT02413372 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Alcoholic Steatohepatitis

Interventions

DRUG: BMS-986036
DRUG: BMS-986036
DRUG: Placebo

Sponsor

Bristol-Myers Squibb